Welcome to Prospect! We use the same data as VCs to help you find the best startups and understand what your equity is likely to be worth.
View more companies

Zocdoc

Zocdoc is an online healthcare marketplace where patients can find in-network doctors and instantly book in-person or virtual appointments.

$3.42

Secondary Market Price

Updated: 
Jan 2026
Current Preferred Price
Date:
Sign in to view
Prospect Projected Preferred
Current FMV
Date:
Sign in to view
Prospect Projected FMV
$1.8B
Company Valuation
Updated: 
Jan 2026
Health
Industry
New York, NY
Headquarters
2007
Year Founded
1,200+
Employee Count

How Zocdoc Measures Up

To help you manage your Zocdoc equity, Prospect has run the company through our machine learning model.

Prospect Rating

--

This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.

Exit Risk

--

Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.

Funding Stage

TBD

A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.

$3.42
Est val $1.8B
--
Jan 30, 2026

Create a free account to unlock real-time secondary market prices and future projections of Zocdoc's value.

Sign up to Unlock the Latest Data
Failed to load data. Using sample data.
Loading chart…

Data will be available soon.
Sign up to receive notifications when it is available.

Sign up to get notified
Sign up to Unlock the Latest Data

Prospect Projected Future Zocdoc Prices

Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Zocdoc's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.

Powerful tools to earn more from your equity

Company Description

Zocdoc operates as an online healthcare marketplace connecting patients with medical providers. Through its website and app, users can find in-network doctors, see real-time appointment availability, and book in-person or virtual visits. The company utilizes a pay-per-booking business model, where providers are charged a fee for each new patient acquired through the platform. Founded in 2007, Zocdoc originally used a subscription model, charging doctors an annual fee. Facing slow growth, the company pivoted around 2015 to its current transaction-based system, which involved significant operational and technical adjustments but ultimately led to a successful turnaround.

The company is now focused on expanding its services beyond its core marketplace. Future plans include powering insurance directories and deepening integrations with platforms like Google and Apple Maps. Recent developments include the launch of Zo, a voice AI assistant to automate patient calls, and the publication of its "What Patients Want" report, which details trends in patient behavior. In March 2021, Zocdoc raised $150 million in a private equity round led by Francisco Partners to fuel its expansion efforts.

Zocdoc Notable Investors

  • Khosla Ventures
  • Founders Fund
  • Goldman Sachs
  • DST Global
  • Atomico
  • Baillie Gifford
  • Francisco Partners
  • Bezos Expeditions
  • SV Angel

Zocdoc Founders

  • Co-Founder, Cyrus Massoumi
  • Co-Founder, Nick Ganju
  • Co-Founder, Oliver Kharraz

Peer Group Comparison

Vs Peer Group of >$4B Startups

Frequently Asked Questions

Is Anduril worth joining?

Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.

Is Zocdoc worth joining?

Deciding whether to join any company is a personal choice that depends on your career goals and alignment with the company's mission and culture. If you receive an equity offer, understanding its potential value is a critical part of your financial decision-making.

What should I do with my Zocdoc stock?

Managing private company stock involves navigating complex tax implications and making strategic decisions about when to exercise options or sell shares. Platforms like Prospect provide customized strategies to help you optimize the timing of these decisions and maximize your potential returns.

Can you sell Zocdoc stock?

It is often possible to sell shares in a private company through secondary markets or company-approved tender offers, though restrictions may apply. Tools are available to help you navigate these sales, optimize which shares to sell for tax purposes, and decide how much to sell.

How can I find the value of my Zocdoc stock?

Valuing private stock is challenging as it isn't traded publicly, but you can use specialized platforms to get an informed projection. For example, Prospect uses predictive models that analyze market data to help you forecast the potential future value of your equity.

What is Zocdoc's equity worth?

The precise value of a private company's equity is not public information and can fluctuate based on performance and market conditions. To understand what your specific Zocdoc holdings could be worth, you can use financial modeling tools that project a range of potential outcomes for the company.

What is Zocdoc's stock ticker symbol?

As a privately held company, Zocdoc does not have a stock ticker symbol. Ticker symbols are only assigned to companies when they list their shares for trading on a public stock exchange like the NYSE or NASDAQ.

Can I buy or sell Zocdoc stock?

Selling private stock may be possible for employees and early investors through secondary markets, and platforms like Prospect offer tools to assist with this process. Buying stock in a private company, however, is typically restricted to accredited investors and is not generally open to the public.

What is the criteria to buy or invest in Zocdoc stock?

Investing in a private company like Zocdoc is usually reserved for institutional investors and accredited investors who meet specific income and net worth thresholds set by regulators. These investment opportunities are not typically available to the general public before an initial public offering (IPO).

Ready to unlock insights on top performing startups?
Ready to unlock insights on top performing startups?